Abstract
Glioblastoma represents a devastating diagnosis for the patient, considering that, without treatment, its average survival is only 4 months. This time is increased to 12 months after physiological resection followed by radiotherapy, with the combination of temozolomide (TMZ), standard chemotherapy, adding only another 3 months to this period. Precisely the frequent development of resistan…